Causes of fever and value of C-reactive protein and procalcitoinin in differentiating infections from paraneoplastic fever

Supportive Care in Cancer

Volumn 12, Issue 8, 2004, Pages 593-598

  Penel, Nicolas ^a   Fournier, Charles ^a   Clisant, Stéphanie ^a   N'Guyen, Michèle ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

C reactive protein; Cancer; Diagnosis; Fever; Infection; Paraneoplastic fever; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; BACTERIAL INFECTION; CANCER PATIENT; FEMALE; FEVER; GRAM POSITIVE COCCI; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

EID: 4043107909     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0602-9     Document Type: Article

References (33)

1. Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434-436
2. Barnes C, Ignjatovic V, Newall F, Carlin J, Ng F, Hamilton S, Ashley D, Waters K, Monagle P (2002) Change in serum procalcitonin (delta PCT) predicts, the clinical outcome of children admitted with febrile neutropenia. Br J Haematol 118:1197-1198
3. Baumel H, Deixone B, Bruel JM, Dubois A, Lopez C, et al (1987) Cancers du pancréas exocrine. In In Cancers Digestifs. Zeintoun P, eds. Paris, Flammarion Médecine-Sciences, 317-388
4. Bernard L, Ferriere F, Casassus P, et al (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27:914-915
5. Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Scheman S, Negrier S, Philip T, Favrot M (1997) Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 72:424-430
6. Blijlevens NM, Donnely JP, Meis JF, DE Keizer MH, De Pauw BE (2000) Procalcitonin does not discriminate infection from inflammation after allogenic marrow transplantation. Clin Diagn Lab Immunol 7:889-892
7. Boggs DR, Frei E HI (1960) Clinical studies of fever and infection in cancer. Cancer 13:1240-1253
8. Borries-Azeau A, Givarc'h B (1981) 683 tumeurs rétropé ritonéales primitives. In: Martin C (ed) Rapport du 83éme congrès de Chirurgie. Masson, Paris
9. Browder AA, Huff JW, Petersdorf RG (1965) The significance of fever in neoplastic disease. Ann Intern Med 55:932-949
10. Chang JC (1989) Neoplastic fever, a proposal for diagnosis. Arch Intern Med 149:1728-1730
11. Dandonna P, Nix D, Wilson MF, Aljata A, Love J, Assicot M (1994) Procalcitonin increase after endotoxin infections in normal subjects. J Clin Endocrinol Metabol 79:1605-1608
12. Engel A, Mack E, Kern P, Kern WV (1998) An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteriemia and complicated infection in neutropenic cancer patients. Infection 26:213-221
13. Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31:185-189
14. Fenster LF, Klastin G (1961) Manifestations of metastatic tumours of the liver. Am J Med 31:238-248
15. Fleischack G, Kambeck I, Cipic D, Hassan C, Bode U (2000) Procalcitonin in pediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 111:1093-1102
16. Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, et al (1997) Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 41:832-40
17. Gerard Y, Hober D, Assicot M, Alfandari S, Ajana F, Bourez JM, et al (1997) Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 35:41-46
18. Ghillani PP, Motte P, Troalen F, Julienne A, Gardet P, Le Chevalier T, et al (1989) Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 49:6845-6851
19. Giamarellos-Bourboulis EJ, Grecka P, Poulajou G, Anargyrou K, Katsilambros N, Giamarellou H (2001) Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 32:1718-1728
20. Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H (2002) Procalcitonin:a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28:1351-1356
21. Kallio R, Surcel HM, Bloigu A, Syrjala H (2000) C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 889-894
22. Kallio R, Bloigu A, Surcel HM, Syrjala H (2001) C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 9:124-128
23. Klastersky J, Weerts D, Hensgens C, Debusscher L (1973) Fever of unexplained origin in patients with cancer. Eur J Cancer 9:649-656
24. Lestin F, Lestin HG, Burstein C, Anders O, Freund M (1998) Provisional experience with procalcitonin, C-reactive protein, neopterin, selected cytokines and hemostatic parameters in patients with malignant hematological diseases and febrile neutropenia induced by cytostatic treatment. Clin Lab 44:451-461
25. Penel N, Fournier C, Degardin M, Kouto H, N'Guyen M (2001) Fièvre et tumeur solide: valeur diagnostique de la procalcitonine et de la protéine C réactive. Rev Med Interne 22:706-714
26. Pizzo PA, Robichaud KJ, Wasley R (1982) Fever in pediatric and young adults with cancer. A prospective study of 1001 episodes. Medicine 61:153-165
27. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Berger HG (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832-840
28. Richie AWS, de Kemion JB (1987) The natural history and clinical features of renal carcinoma. Semin Nephrol 7:131-135
29. Rosenberg SA, Diamond HD, Jaslowitz B, Crower LF (1961) Lymphosarcoma: a review of 1269 cases. Medicine 40:31-39
30. Ruokonen E, Nousianen T, Pulkki K, Takala J (1999) Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 18:283-285
31. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Bin C (2003) Procalcitonin: a useful discriminator between febrile condition of different origin in hemato-oncological patients? Ann Hematol 82:98-103
32. Schwenger V, Sis J, Breitbart A, Andrassy K (1996) CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 24:434-436
33. Urgate H, Silva E, Mercan D, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Critical Care Med 27:452-453